3,690
edits
Tranexamic Acid: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
[https://journals.lww.com/anesthesia-analgesia/fulltext/2022/09000/tranexamic_acid__current_knowns_and_unknowns.4.aspx Tranexamic Acid: Current Knowns and Unknowns] | [https://journals.lww.com/anesthesia-analgesia/fulltext/2022/09000/tranexamic_acid__current_knowns_and_unknowns.4.aspx Tranexamic Acid: Current Knowns and Unknowns] | ||
References | |||
1. Goobie, S.M., Patient Blood Management Is a New Standard of Care to Optimize Blood Health. Anesth Analg, 2022. 135(3): p. 443-446. | |||
2. Nellis, M.E., et al., Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB). Pediatr Crit Care Med, 2022. 23(1): p. 34-51. | |||
3. Valentine, S.L., J.M. Cholette, and S.M. Goobie, Transfusion Strategies for Hemostatic Blood Products in Critically Ill Children: A Narrative Review and Update on Expert Consensus Guidelines. Anesth Analg, 2022. 135(3): p. 545-557. | |||
4. Yaster, M., et al., A comparison of nitroglycerin and nitroprusside for inducing hypotension in children: a double-blind study. Anesthesiology, 1986. 65(2): p. 175-179. | |||
5. Patel, P.A., et al., Update on Applications and Limitations of Perioperative Tranexamic Acid. Anesth Analg, 2022. 135(3): p. 460-473. | |||